Home › Digestive Diseases › New Jersey
Digestive Diseases clinical trials in New Jersey
3 studies for Digestive Diseases are looking for participants at sites in New Jersey.
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- 89bio Clinical Study Site, Somers Point
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Oct 23, 2026 · NCT06419374A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- 89bio Clinical Study Site, Freehold
- 89bio Clinical Study Site, Warren Township
RecruitingPhase 3
Ages 18 to 80 · All sexes · Updated Oct 23, 2026 · NCT06318169Product Surveillance Registry
- Camden
- Marlton
- Morristown
- and 2 more
RecruitingObservational study
All ages · All sexes · Updated Oct 20, 2026 · NCT01524276From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.